-
1
المؤلفون: Ljung, Rolf, Chan, Anthony K C, Glosli, Heidi, Afonja, Olubunmi, Becker, Bastian, Tseneklidou-Stoeter, Despina, Mancuso, Maria Elisa, Saulyte-Trakymiene, Sonata, Kenet, Gili
المصدر: Thrombosis and Haemostasis. 123(1):27-39
مصطلحات موضوعية: Humans, Child, Infant, Factor VIII/adverse effects, Hemophilia A/drug therapy, Treatment Outcome, Hemorrhage/chemically induced, Medicin och hälsovetenskap, Klinisk medicin, Hematologi, Medical and Health Sciences, Clinical Medicine, Hematology
الوصول الحر: https://lup.lub.lu.se/record/5e753ac2-91ce-4c49-8fe2-26d4ccd37b4eTest
http://dx.doi.org/10.1055/s-0042-1757876Test -
2دورية أكاديمية
المؤلفون: Kuter, David J, Mayer, Jiri, Efraim, Merlin, Bogdanov, Lachezar H, Baker, Ross, Kaplan, Zane, Garg, Mamta, Trněný, Marek, Choi, Philip Y, Jansen, A J Gerard, McDonald, Vickie, Bird, Robert, Gumulec, Jaromir, Kostal, Milan, Gernsheimer, Terry, Ghanima, Waleed, Daak, Ahmed, Cooper, Nichola
مصطلحات موضوعية: Hemorrhage - chemically induced, Humans, Purpura, Thrombocytopenic, Idiopathic - chemically induced, Idiopathic - drug therapy, Receptors, Fc, Thrombocytopenia - chemically induced, Thrombopoietin - therapeutic use, Treatment Outcome
وصف الملف: pdf
العلاقة: ispartof: Blood advances spage 1715 epage 1724 issue 7 vol 8; 991005656566207891; https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Long-term-treatment-with-rilzabrutinib-in-patients/991005656566207891Test; https://researchportal.murdoch.edu.au/view/delivery/61MUN_INST/12161236700007891/13161236690007891Test; alma:61MUN_INST/bibs/991005656566207891
الإتاحة: https://doi.org/10.1182/bloodadvances.2023012044Test
https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Long-term-treatment-with-rilzabrutinib-in-patients/991005656566207891Test
https://researchportal.murdoch.edu.au/view/delivery/61MUN_INST/12161236700007891/13161236690007891Test -
3دورية أكاديمية
المؤلفون: Gilbert, Benoît Thomas P., Mongin, Denis, Aymon, Romain Victor Rudolf, Lauper, Kim, Laedermann, Cédric, Perrier, Clémentine, Mueller, Ruediger, Courvoisier, Delphine, Finckh, Axel
المصدر: ISSN: 2044-6055 ; BMJ open, vol. 14, no. 3 (2024) e072300.
مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Epidemiology, Rheumatology, Statistics & research methods, Antirheumatic Agents / therapeutic use, Arthritis, Rheumatoid / chemically induced, Rheumatoid / drug therapy, Azetidines, Biological Products / therapeutic use, Cohort Studies, Humans, Prospective Studies, Purines, Pyrazoles, Sulfonamides, Switzerland, Treatment Outcome, Baricitinib, Antirheumatic Agents, Biological Products
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38479734; https://archive-ouverte.unige.ch/unige:178527Test; unige:178527
-
4دورية أكاديمية
المؤلفون: Potpara, Tatjana, Grygier, Marek, Haeusler, Karl Georg, Nielsen-Kudsk, Jens Erik, Berti, Sergio, Genovesi, Simonetta, Marijon, Eloi, Boveda, Serge, Tzikas, Apostolos, Boriani, Giuseppe, Boersma, Lucas V A, Tondo, Claudio, De Potter, Tom, Lip, Gregory Y H, Schnabel, Renate B, Bauersachs, Rupert, Senzolo, Marco, Basile, Carlo, Bianchi, Stefano, Osmancik, Pavel, Schmidt, Boris, Landmesser, Ulf, Doehner, Wolfram, Hindricks, Gerhard, Kovac, Jan, Camm, A John
المصدر: Potpara , T , Grygier , M , Haeusler , K G , Nielsen-Kudsk , J E , Berti , S , Genovesi , S , Marijon , E , Boveda , S , Tzikas , A , Boriani , G , Boersma , L V A , Tondo , C , De Potter , T , Lip , G Y H , Schnabel , R B , Bauersachs , R , Senzolo , M , Basile , C , Bianchi , S , Osmancik , P , Schmidt , B , Landmesser , U , Doehner , W ....
مصطلحات موضوعية: Anticoagulation, Atrial fibrillation, Bleeding, Left atrial appendage closure, Left atrial appendage occlusion, Prevention, Stroke, Physicians, Humans, Treatment Outcome, Anticoagulants/adverse effects, Thromboembolism/etiology, Consensus, Hemorrhage/chemically induced, Atrial Appendage/surgery, Stroke/prevention & control, Adult, Atrial Fibrillation/complications, Vitamin K
الإتاحة: https://doi.org/10.1093/europace/euae035Test
https://pure.au.dk/portal/en/publications/7a159a57-48ff-496c-b7e5-b8741528f1abTest
http://www.scopus.com/inward/record.url?scp=85190694084&partnerID=8YFLogxKTest -
5دورية أكاديمية
المؤلفون: Kwon, Soonil, Lee, So-Ryoung, Choi, Eue-Keun, Lee, Kyung-Yeon, Choi, JungMin, Ahn, Hyo-Jeong, Oh, Seil, Lip, Gregory Yoke Hong
المصدر: Kwon , S , Lee , S-R , Choi , E-K , Lee , K-Y , Choi , J , Ahn , H-J , Oh , S & Lip , G Y H 2024 , ' Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study ' , Vascular Health and Risk Management , vol. 20 , pp. 231-244 . https://doi.org/10.2147/VHRM.S455530Test
مصطلحات موضوعية: Administration, Oral, Atrial Fibrillation/diagnosis, Drug Administration Schedule, Factor Xa Inhibitors/adverse effects, Hemorrhage/chemically induced, Humans, Multicenter Studies as Topic, Perioperative Care/methods, Prospective Studies, Pyrazoles/adverse effects, Pyridines/adverse effects, Pyridones/adverse effects, Registries, Research Design, Risk Assessment, Risk Factors, Rivaroxaban/adverse effects, Thiazoles, Time Factors, Treatment Outcome, bleeding, oral anticoagulant, atrial fibrillation, perioperative care, direct factor Xa inhibitor
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.2147/VHRM.S455530Test
https://vbn.aau.dk/da/publications/c745a5c9-6a22-436d-8bd0-4bf31d82a9d1Test
https://vbn.aau.dk/ws/files/717193986/Kwon_et_al._2024_._Perioperative_Management_in_Patients_with_Atrial_Fibrillation_Treated_with_Non-Vitamin_K_Antagonist_Oral_Anticoagulants_Undergoing_Minor_Bleeding_Risk_Procedure_-_Rationale_and_Protocol_for_the_PERIXa_Study.pdfTest
http://www.scopus.com/inward/record.url?scp=85194026459&partnerID=8YFLogxKTest -
6دورية أكاديمية
المؤلفون: Ahn, Hyo-Jeong, Lee, So-Ryoung, Choi, JungMin, Lee, Kyung-Yeon, Kwon, Soonil, Choi, Eue-Keun, Oh, Seil, Lip, Gregory Y. H.
المصدر: Ahn , H-J , Lee , S-R , Choi , J , Lee , K-Y , Kwon , S , Choi , E-K , Oh , S & Lip , G Y H 2024 , ' Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study ' , Europace , vol. 26 , no. 2 , euae033 . https://doi.org/10.1093/europace/euae033Test
مصطلحات موضوعية: Administration, Oral, Aged, Anticoagulants/adverse effects, Atrial Fibrillation/diagnosis, Brain Ischemia, Cohort Studies, Fibrinolytic Agents/adverse effects, Hemorrhage/chemically induced, Humans, Ischemic Stroke, Male, Platelet Aggregation Inhibitors/adverse effects, Retrospective Studies, Risk Factors, Stroke/diagnosis, Treatment Outcome, Atrial fibrillation, Antithrombotics, Antiplatelet, Oral anticoagulation, Ischaemic stroke
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1093/europace/euae033Test
https://vbn.aau.dk/da/publications/ed0cd2ac-ea73-4e08-a10c-ab7a91c48973Test
https://vbn.aau.dk/ws/files/676573205/Ahn_et_al._2024_._Association_between_antithrombotic_therapy_after_stroke_in_patients_with_atrial_fibrillation_and_the_risk_of_net_clinical_outcome_-_an_observational_cohort_study.pdfTest
http://www.scopus.com/inward/record.url?scp=85185282340&partnerID=8YFLogxKTest -
7دورية أكاديمية
المؤلفون: Scheen, André, WALLEMACQ, Caroline, Lancellotti, Patrizio
المصدر: Revue Médicale de Liège, 78 (10), 593-600 (2023-10)
مصطلحات موضوعية: LKC0U3A8NJ (evolocumab), EC 3.4.21.- (PCSK9 protein, human), EC 3.4.21.- (Proprotein Convertase 9), Anticholesteremic Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cholesterol, LDL, PCSK9 Inhibitors, Humans, Proprotein Convertase 9, Anticholesteremic Agents/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Cholesterol, LDL/therapeutic use, Cardiovascular Diseases/chemically induced, Secondary Prevention, Treatment Outcome, Atherosclerosis/drug therapy/etiology/prevention & control, Atherosclerotic cardiovascular disease, Evolocumab, Familial hypercholesterolaemia, LDL cholesterol, Monoclonal antibody, PCSK9, Human health sciences, Cardiovascular & respiratory systems, Sciences de la santé humaine, Systèmes cardiovasculaire & respiratoire
العلاقة: urn:issn:0370-629X; urn:issn:2566-1566
الوصول الحر: https://orbi.uliege.be/handle/2268/318578Test
-
8دورية أكاديمية
المصدر: Krittayaphong , R , Winijkul , A , Methavigul , K & Lip , G Y H 2023 , ' Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway : A Report From the COOL-AF Registry ' , Journal of the American Heart Association , vol. 12 , no. 3 , e028463 . https://doi.org/10.1161/JAHA.122.028463Test
مصطلحات موضوعية: Aged, Anticoagulants/therapeutic use, Atrial Fibrillation/epidemiology, Blood Pressure, Critical Pathways, Embolism/etiology, Female, Heart Failure/drug therapy, Hemorrhage/chemically induced, Humans, Intracranial Hemorrhages/chemically induced, Male, Prospective Studies, Registries, Stroke/epidemiology, Treatment Outcome, Warfarin/therapeutic use, death, time in therapeutic range, systolic blood pressure, ABC pathway, major bleeding, ischemic stroke
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1161/JAHA.122.028463Test
https://vbn.aau.dk/da/publications/b13017cb-365e-4c40-a5cb-b594ff641927Test
https://vbn.aau.dk/ws/files/516094045/Krittayaphong_et_al._2023_._Impact_of_Achieving_Blood_Pressure_Targets_and_High_Time_in_Therapeutic_Range_on_Clinical_Outcomes_in_Patients_With_Atrial_Fibrillation_Adherent_to_the_Atrial_Fibrillation_Better_Care_Pathway.pdfTest
http://www.scopus.com/inward/record.url?scp=85147536865&partnerID=8YFLogxKTest -
9دورية أكاديمية
المساهمون: Chi Young Shim, Jiwon Seo, Young Jin Kim, Seung Hyun Lee, Raffaele De Caterina, Sak Lee, Geu-Ru Hong, Explore the Efficacy and Safety of Edoxaban in Patients after Heart Valve Repair or Bioprosthetic Valve Replacement (ENAVLE) study group, Kim, Young Jin
مصطلحات موضوعية: Anticoagulants / adverse effects, Atrial Fibrillation* / drug therapy, Hemorrhage / chemically induced, Humans, Prospective Studies, Stroke* / prevention & control, Thromboembolism* / etiology, Thromboembolism* / prevention & control, Treatment Outcome, Warfarin / adverse effects, NOACs, efficacy, non-vitamin K antagonist oral anticoagulants, oral anticoagulants, safety, valve surgery, warfarin
العلاقة: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY; J01906; OAK-2023-00225; OAK-2023-00226; OAK-2023-00227; OAK-2023-00228; OAK-2023-00229; OAK-2023-00230; OAK-2023-00231; OAK-2023-00232; OAK-2023-00233; OAK-2023-00235; https://ir.ymlib.yonsei.ac.kr/handle/22282913/193748Test; https://www.sciencedirect.com/science/article/pii/S0022522321002282Test; T202301741; JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, Vol.165(1) : 58-67.e4, 2023-01
الإتاحة: https://doi.org/10.1016/j.jtcvs.2021.01.127Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/193748Test
https://www.sciencedirect.com/science/article/pii/S0022522321002282Test -
10دورية أكاديمية
المؤلفون: van der Sangen, Niels M R, Küçük, I Tarik, Sivanesan, Shabiga, Appelman, Yolande, Ten Berg, Jurriën M, Verburg, Ashley, Azzahhafi, Jaouad, Arkenbout, E Karin, Kikkert, Wouter J, Pisters, Ron, Jukema, J Wouter, Arslan, Fatih, van 't Hof, Arnoud, Ilhan, Mustafa, Hoebers, Loes P, van der Schaaf, René J, Damman, Peter, Woudstra, Pier, van de Hoef, Tim P, Bax, Matthijs, Anthonio, Rutger L, Polad, Jawed, Adriaenssens, Tom, Dewilde, Willem, Zivelonghi, Carlo, Laanmets, Peep, Majas, Risko, Dijkgraaf, Marcel G W, Claessen, Bimmer E P M, Henriques, José P S
المساهمون: Team Medisch
مصطلحات موضوعية: Acute Coronary Syndrome/drug therapy, Aspirin, Drug Therapy, Combination, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Randomized Controlled Trial, Multicenter Study, Journal Article, Research Support, Non-U.S. Gov't
وصف الملف: application/pdf